Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA)
Diane E. Griffin, M.D., Ph.D.
Vice President, National Academy of Sciences, University Distinguished Service Professor, Johns Hopkins Bloomberg School of Public Health
Karin Bok, M.S., Ph.D.
Acting Deputy Director, Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, NIAID, NIH
Ofer Levy, M.D., Ph.D.
Director, Precision Vaccines Program; Senior Physician in Infectious Diseases, Boston Children's Hospital;
Professor, Harvard Medical School
Arturo Casadevall, M.D.
Chair, Department of Molecular Microbiology and Immunology, Bloomberg Distinguished Professor, JH School of Medicine
Tonya Villafana, Ph.D.
Vice President, Global Franchise Head, Infection, AstraZeneca
Amy Finan
Chief Executive Officer, Sabin Vaccine Institute
Mark Emalfarb, Ph.D.
Chief Executive Officer, Dyadic International, Inc.
M. Javad Aman, M.D.
President and CSO, AbVacc, Inc.
Stephen L. Hoffman, M.D.
Chief Executive and Scientific Officer, Sanaria Inc.
Jacqueline Miller, M.D.
Senior Vice President, Head of Development, Infectious Diseases, Moderna
Trudy G. Morrison, Ph.D.
Professor, Microbiology and Physiological Systems, UMass Chan Medical School
Andrew Lees, Ph.D.
CEO/CSO, Fina Biosolutions
Sonia Stoszek, Ph.D.
Executive Director, Program Leader, Infectious Disease, RSV Older Adult Vaccine, Moderna
Martin Moore, Ph.D.
Chief Scientific Officer, Meissa Vaccines, Inc.
Paolo Lusso, M.D., Ph.D.
Chief, Section of Viral Pathogenesis, Laboratory of Immunoregulation, NIAID, NIH
Steffen Mueller, Ph.D.
President & CSO Codagenix, Inc.
Masaru Kanekiyo, Ph.D.
Chief, Molecular Immunoengineering Section, Vaccine Research Center, NIAID, NIH
Marco Pravetoni, Ph.D.
Director, Center for Medication Development for Substance Use Disorders and Overdose, University of Washington School of Medicine
Denise L. Faustman, M.D., Ph.D.
Director of Immunobiology, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School
Cara Fiore, Ph.D.
Senior Regulatory Reviewer, Microbiologist, Office of Vaccines Research and Review, CBER/OMTP/FDA
Jörg Hermann Fritz, Ph.D.
Director, McGill Research Center on Complex Traits (MRCCT); Associate Professor, Departments of Microbiology and Immunology, and Physiology, McGill University
Liang Huang, Ph.D.
Founder & CEO, Coderna.ai, Associate Professor, Oregon State University
Matthew Ollerton, Ph.D.
Division of Infectious Diseases, Department of Medicine, University of Arizona
Robert Daniels, Ph.D.
Principal Investigator and CMC Reviewer in the Laboratory of Pediatric and Respiratory Viral Diseases, Office of Vaccines Research and Review, CBER, FDA
Changkeun "David" Lee, Ph.D.
Director, Head of Protein Biochemistry, CSL Seqirus
Nathan Krump, Ph.D.
Research & Application Scientist, Integral Molecular
Vira Bitko, Ph.D.
VP, Head of Vaccines, RVAC Medicines Inc.
Sreenivas Gannavaram, Ph.D.
Biologist, Laboratory of Emerging Pathogen, Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA
Yongjun Sui, Ph.D.
Associate Scientist, Vaccine Branch, Center for Cancer Research, National Cancer Institute, NIH
Heather Friberg, Ph.D.
Chief, Department of Virus-Host Interactions, Viral Diseases Branch, Walter Reed Army Institute of Research
Venigalla B. Rao, Ph.D.
Director, Bacteriophage Medical Research Center, Professor of Biology, The Catholic University of America
Minoru S.H. Ko, M.D., Ph.D.
Chief Scientific Officer, Elixirgen Therapeutics, Inc.
Associate Professor, Department of Microbiology, Faculty of Medicine, University of Hong Kong; Program Leader, Centre for Virology, Vaccinology and Therapeutics
Susan R. Trammell, Ph.D.
Professor, Department of Physics and Optical Science, University of North Carolina at Charlotte
Sylvain Baize, Ph.D.
Unité de Biologie des Infections Virales Emergentes, Institut Pasteur;
Centre International de Recherche en Infectiologie, Université de Lyon
Daniel J.J. Carr, Ph.D., FARVO
Professor of Microbiology, Immunology, and Ophthalmology,
The University of Oklahoma Health Sciences Center
Clarisa B Palatnik de Sousa, Ph.D.
Professor of Microbiology, Fellow of the International Society for Vaccines, Universidade Federal do Rio de Janeiro
Masfique Mehedi, Ph.D.
Assistant Professor, University of North Dakota School of Medicine & Health Sciences
Courtney Finch, Ph.D.
Director of Pre-Clinical, Research & Development, Sabin Vaccine Institute
Darrell R. Galloway, Ph.D.
Research Professor, Department of Molecular Pharmaceutics College of Pharmacy, University of Utah
Marie-Claire Gauduin, Ph.D.
Professor, Disease Intervention and Prevention, Texas Biomedical Research Institute
S. Indu Rupassara, Ph.D., MBA
Co-Founder & CEO, FruitVaccine, Inc.
Richard Anthony, Ph.D.
Founder and President, Vacunax, Inc.
Zhangyong Hong, Ph.D.
Professor, Director of the Department of Biochemistry and Molecular Biology,
School of Life Sciences, Nankai University
Reza Nejat, M.D.
Anesthesiology and Critical Care Dept., Laleh Hospital, Iran; Anti-Doping, Nutrition and Metabolism Consultant, Eurasia Division, World Powerlifting Ltd., Australia
Pi-Hui Liang, Ph.D.
Founder and CEO ImmunAdd, Inc.
Nicole Skinner, M.D., Ph.D.
Principal Investigator, Center for Vaccines and Immunity, The Abigail Wexner Research Institute, Nationwide Children’s Hospital
Karen Anderson, Ph.D.
Professor and Associate Dean, Biodesign Institute, Arizona State University
Jyothi Rengarajan, Ph.D.
Professor of Medicine, Division of Infectious Diseases, Emory University School of Medicine; Co-Director, Emory/Georgia TRAC & Emory Tuberculosis Center
Xingmin Sun, Ph.D.
Associate Professor, Dept. of Molecular Medicine, Morsani College of Medicine; Dept. of Chemistry, University of South Florida
Justin D. Radolf, Ph.D.
Professor of Medicine and Pediatrics, UConn Health; Director of Research, Department of Medicine, UConn Health
Xinyuan Chen, Ph.D.
Associate Professor, Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island
M. Amin Khan, Ph.D.
Chief Science Advisor, Afrigen Biologics and Vaccines, South Africa
Narayan Nair, M.D.
Director, Division of Pharmacovigilance, Office of Biostatistics and Pharmacovigilance, CBER, FDA
Hong Xin, M.D., Ph.D.
Associate Professor, Microbiology and Immunology, Louisiana State University Health Sciences Center
Stephen Angeloni, Ph.D.
Sr. Field Application Scientist, Luminex Corporation
Sukrit Srivastava
Guest Scientist, Department for Structural Infection Biology, Center for Structural Systems Biology (CSSB), Deutsches Elektron Synchrotron (DESY), Germany
W. John Martin, Ph.D.
Institute of Progressive Medicine
Aaron Esser-Kahn, Ph.D.
Professor, Pritzker School of Molecular Engineering, William Eckhardt Research Center, The University of Chicago
Young Researchers
Ralf Gabriels, Ph.D.
VIB-UGent Center for Medical Biotechnology and Department of Biomolecular Medicine, Ghent University, Belgium
Jorge Armero Gimenez, Ph.D.
Technology Center LenioBio GmbH, Germany
Sanda Ravlic, Ph.D.
Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, Croatia
